Amlodipine modulation of analgesic effect of non-steroidal anti-inflammatory drugs in rheumatoid arthritis, comorbid with arterial hypertension

  • N. M. Seredynska Institute of Pharmacology and Toxicology, The National Academy of Medical Sciences of Ukraine
  • V. I. Kornienko Kharkiv Zooveterinary Academy
  • D. V. Kibkalo Kharkiv Zooveterinary Academy
  • O. S. Suvorova Institute of Pharmacology and Toxicology, The National Academy of Medical Sciences of Ukraine
  • O. M. Marchenko Institute of Pharmacology and Toxicology, The National Academy of Medical Sciences of Ukraine
  • O. V. Ladogubets Kharkiv Zooveterinary Academy
Keywords: rheumatoid arthritis; arterial hypertension; amlodipine; non-steroidal anti-inflammatory drugs; analgesic effect.


 With the interaction of drugs belonging to different pharmacotherapeutic groups – nonsteroidal anti-inflammatory and antihypertensive – against the background of comorbid arterial hypertension with rheumatoid arthritis, the activity and safety of drugs may change with their combined use. Changes in the analgesic activity of nonsteroidal anti-inflammatory drugs, different in their selectivity to the types of cyclooxygenase (diclofenac, nimesulide and celecoxib), under the conditions of their long-term combined use with amlodipine in different periods of inflammation against the background of hypertension should be studied. Using the model of adjuvant arthritis comorbid with hypertension, in experiments on nonlinear mature white rats, the threshold of pain sensitivity has been determined by means of the “tail flick” test. Hypertension was caused by salt load with 1% sodium chloride solution for drinking with free access to it. Adjuvant arthritis was induced by the introduction of complete Freund’s adjuvant into the plantar aponeurosis of the hind limb of each animal with the established arterial hypertension. Against the background of arterial hypertension and comorbid pathology, there was an increase in the threshold of pain sensitivity observed in rats, which indicated the development of hypoalgesia. When combined, amlodipine enhanced the analgesic activity of diclofenac during 60 days of observation, slightly heightened the analgesic effect of nimesulide – up to 42 days, the effect of Celecoxib – in the acute period and the period of manifestation of adjuvant arthritis against the background of hypertension. The antinociceptive effect of diclofenac with amlodipine and celecoxib with amlodipine exceeded the analgesic effect of the combined nimesulide with amlodipine use against the background of comorbid pathology. The results obtained can be taken into account under the conditions of prescribing drugs belonging to the studied pharmacotherapeutic groups. It is likely that the use of diclofenac for analgesia against the background of comorbid conditions is only appropriate in the acute period of rheumatoid arthritis. The use of nimesulide to achieve an analgesic effect in the recurrence of rheumatoid arthritis against the background of hypertension is appropriate in the acute period and in the period of the inflammatory process attenuation. A highly selective coxib group cyclooxygenase-2 inhibitor, celecoxib, can reduce pain during the acute period of arthritis and during the manifestation of an inflammatory reaction that has developed against the background of arterial hypertension.


Antivalle, M., Chevallard, М., Battellino, M., Batticciotto, A., Chiara, D. M., Mutti, A., Rigamonti, F., Varisco, V., Bongiovanni, S., Atzeni, F., & Sarzi-Puttini, P. (2013). Reduced response to biologic treatments in rheumatoid argritis patients affected by arterial hyperthension. Arthritis and Rheumatology, 65(10), 462–465.

Badyal, D. K., Lata, H., & Dadhich, A. P. (2003). Animal models of hypertension and effect of drugs. Indian Journal Pharmacology, 35, 349–362.

Bohr, D. F., & Dominiczak, A. F. (1991). Experimantal hypertension. Hypertension, 17(1), 39–44.

Choudhary, N., Bhatt, L. K., & Prabhavalkar, K. S. (2018). Experimental animal models for rheumatoid arthritis. Immunopharmacology and Immunotoxicology, 40(3), 193–200.

Combe, B., Swergold, G., McLay, J., McCarthy, T., Zerbini, C., Emery, P., Connors, L., Kaur, A., Curtis, S., Laine, L., & Cannon, C. P. (2009). Cardiovascular safety and gastrointestinal tolerability of etoricoxib vs diclofenac in a randomized controlled clinical trial (The MEDAL study). Rheumatology, 48(4), 425–432.

Daïen, C. I., Tubery, A., Beurai-Weber, M., du Cailar, G., Picot, M. C., Jaussent, A., Roubille, F., Cohen, J. D., Morel, J., Bousquet, J., Fesler, P., & Combe, B. (2019). Relevance and feasibility of a systematic screening of multimorbidities in patients with chronic inflammatory rheumatic diseases. Joint Bone Spine, 86(1), 49–54.

Darren, L. A., Ashley, M. M., Iain, B. M., & Foo, Y. L. (2013). Animal models of rheumatoid arthritis. European Journal of Immunology, 39(8), 2040–2044.

Dornas, W. C., & Silva, M. E. (2011). Animal models for study of arterial hypertension. Journal of Biosciences, 36(4), 731–737.

Dougados, M. (2016) Comorbidities in rheumatoid arthritis. Current Opinion in Rheumatology, 28(3), 282–288.

Dougados, M., Soubrier, M., Perrodeau, E., Gossec, L., Fayet, F., Gilson, M., Cerato, M. H., Pouplin, S., Flipo, R. M., Chabrefy, L., Mouterde, G., Euller-Ziegler, L., Schaeverbeke, T., Fautrel, B., Saraux, A., Chary-Valckenaere, I., Chales, G., Dernis, E., Richette, P., Mariette, X., Berenbaum, F., Sibilia, J., & Ravaud, P. (2015). Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: Results of a prospective, multicentre, randomised, controlled trial (COMEDRA). Annals of the Rheumatic Diseases, 74(9), 1725–1733.

Dworkin, B. R., Filewich, R. J., Miller, N. E., Craigmyle, N., & Pickering T. G. (1979). Baroreceptor activation reduces reactivity to noxious stimulation: Implications for hypertension. Science, 205(4412), 1299–1301.

Fosbol, E. L., Folke, F., Jacobsen, S., Rasmussen, J. N., Sørensen, R., Schramm, T. K., Andersen, S. S., Rasmussen, S., Poulsen, H. E., Køber, L., Torp-Pedersen, C., & Gislason, G. H. (2010). Cause-specific cardiovascular risk associated with nonsteroidal antiinflammatory drugs among healthy individuals. Circulation: Cardiovascular Quality and Outcomes, 3(4), 395–405.

Furman, N. V., Dolotovskaya, P. V., Malinova, L. I., & Reshetko, O. V. (2019). Komorbidnyye sostoyaniya u bolnykh ostrym koronarnym sindromom v realnoy (povsednevnoy) klinicheskoy praktike [Comorbid conditions in patients with acute coronary syndrome in real (everyday) clinical practice]. Saratov Journal of Medical Scientific Research, 15(3), 821–825 (in Russian).

Grinyuk, V. V., & Zakharov, V. V. (2019). Komorbidnost arterialnoy gipertenzii i khronicheskogo bolevogo sindroma [Comorbidity of arterial hypertension and chronic pain syndrome]. Effective Pharmacotherapy, 15(34), 46–52 (in Russian).

Grinyuk, V. V., Zakharov, V. V., & Vakhnina, N. V. (2016). Gipertoniya i porog boli [Hypertension and pain threshold]. Neurology, Neuropsychiatry, Psychosomatics, 8(4), 57–61 (in Russian).

Gromova, M. A., & Myasoyedova, S. Y. (2014). Arterialnaya gipertenziya, sostoyaniye serdechno-sosudistoy sistemy i kharakteristika boli u bolnykh revmatoidnym artritom [Arterial hypertension, the state of the cardiovascular system and the characteristic of pain in patients with rheumatoid arthritis]. Fundamental Research, 10(4), 651–653 (in Russian).

Haddani, F. Z., Guich, A., Youssoufi, T., Boudhar, E. M., Abouqal, R., Achemlal, L., Allali, F., Bahiri, R., Bouchti, E. I., Maghraoui, E. I., Ghozlani, I., Harzy, T., Hmamouchi, I., Ichchou, L., Mkinsi, O., Niamane, R., & Hassikou, H. (2020). Comorbidities in rheumatoid arthritis: The RBSMR study. International Journal of Clinical Rheumatology, 15(1), 10–14.

Hitchon, C. A., Boire, G., Haraoui, B., Keystone, E., Pope, J., Jamal, S., Tin, D., Thorne, C., & Bykerk, V. P. (2016). CATCH investigators. Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: results from the Canadian early arthritis cohort. Rheumatology, 55(10), 1751–1762.

Karateyev, A. Y. (2011). Tselekoksib, etorikoksib, meloksikam i nimesulid: Dostoinstva i nedostatki [Celecoxib, etoricoxib, meloxicam, and nimesulide: Advantages and disadvantages]. Rheumatology, Traumatology, Orthopedics, 1, 9–19 (in Russian).

Karateyev, A. Y. (2012). Obladayut li protivovospalitelnyye preparaty patogeneticheskim deystviyem [Do anti-inflammatory drugs have a pathogenetic effect] Modern Rheumatology, 2, 13–22 (in Russian).

Karateyev, A. Y. (2014). Kolichestvennaya i kachestvennaya otsenka riska oslozhneniy pri ispolzovanii nesteroidnykh protivovospalitelnykh preparatov kak osnova formirovaniya rekomendatsiy po ikh kontrolyu i profilaktike [Quantitative and qualitative assessment of complication risks in using non-steroidal antiinflammatory drugs as a basis for recommendations on their control and practice]. Modern Rheumatology, 1, 64–72 (in Russian).

Karateyev, A. Y., Nasonov, E. L., Ivashkin, V. T., Martynov, A. I., Yakhno, N. N., Arutyunov, G. P., Abuzarova, G. R., Yevseyev, M. A., Kukushkin, M. L., Kopenkin, S. S., Lila, A. M., Lapina, T. L., Novikova, D. S., Popkova, T. V., Rebrov, A. P., Skorobogatykh, K. V., & Chichasova, N. V. (2018). Ratsionalnoye ispolzovaniye nesteroidnykh protivovospalitelnykh preparatov. Klinicheskiye rekomendatsii [The rational use of non-steroidal anti-inflammatory drugs. Clinical recommendations]. Scientific and Practical Rheumatology, 56, 1–29 (in Russian).

Khimion, L. V., & Klymas’, I. V. (2015). Komorbidnist pry revmatychnykh zakhvoryuvannyakh [Comorbidity in rheumatic diseases]. Ukrainian Journal of Rheumatology, 62(4), 15–18 (in Ukrainian).

Kłodziński, Ł., & Wisłowska, M. (2018). Comorbidities in rheumatic arthritis. Reumatologia, 56(4), 228–233.

Knyazkova, I. I. (2014). Terapevticheskiy potentsial diklofenaka pri ostrom bolevom sindrome [The therapeutic potential of diclofenac in acute pain syndrome]. Medicine of Ukraine, 1, 37–42 (in Russian).

Kolomoyets, M. Y., & Vashenyak, O. O. (2012). Komorbidnist’ i polimorbidnist’ u terapevtychnij praktytsi [Comorbidity and polymorbidity in therapeutic practice]. Ukrainian Medical Journal, 91, 140–143 (in Ukrainian).

Kozachok, N. N., & Selyuk, M. N. (2010). Lider XXI veka v lechenii bolevogo sindroma [The leader of the XXI century in the treatment of pain syndrome]. Ukrainian Medical Journal, 77, 55–58 (in Russian).

Luque, R. A., Redeker, I., Hoffmann, F., Callhoff, J., Zink, A., & Albrecht, K. (2019). Comorbidities in patients with rheumatoid arthritis and their association with patient-reported outcomes: Results of claims data linked to questionnaire survey. Journal Rheumatology, 46(6), 564–571.

Mantel, Ä., Holmqvist, M., Jernberg, T., Wållberg-Jonsson, S., & Askling, J. (2017). Long-term outcomes and secondary prevention after acute coronary events in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 76, 2017–2024.

Mattia, C., Ciarcia, S., Muhindo, A., & Colluzzi, F. (2010). Nimesulide: 25 years later. Minerva Medica, 101(4), 285–293.

Moore, A., Makinson, G., & Chunming, L. (2013). Patient-level pooled analysis of adjudicated gastrointestinal outcomes in celecoxib clinical trials: Meta-analysis of 51,000 patients enrolled in 52 randomized trials. Arthritis Research and Therapy, 15(1), R6.

Myasoyedova, Y. Y. (2012). Rasprostranennost’ i faktory riska arterialnoy gipertenzii pri revmatoidnom artrite [Prevalence and risk factors for arterial hypertension in rheumatoid arthritis]. Scientific and Practical Rheumatology, 2, 31–34 (in Russian).

Naumov, A. V., Tkacheva, O. N., & Khovasova, N. O. (2019). K voprosu o bezopasnosti nesteroidnykh protivovospalitelnykh preparatov u patsiyentov s serdechno-sosudistym riskom [On the safety of non-steroidal anti-inflammatory drugs in patients with cardiovascular risk]. Therapeutic Archive, 1, 108–113 (in Russian).

Nikitina, N. M., Afanasyev, I. A., Romanova, T. A., & Rebrov, A. P. (2015). Osobennosti komorbidnosti u bol’nykh revmatoidnym artritom v raznyye gody nablyudeniya [Features of comorbidity in patients with rheumatoid arthritis in different years of observation]. Modern Rheumatology Journal, 9(1), 39–43 (in Russian).

Oganov, R. G., Denisov, I. N., Simanenkov, V. I., Bakulin, I. G., Bakulina, N. V., Bolduyeva, S. A., Barbarash, O. N., Garganeyeva, N. P., Doshchitsin, V. L., Drapkina, O. M., Dudinskaya, Y. N., Kotovskaya, Y. V., Lila, A. M., Mamedov, M. N., Mardanov, B. U., Miller, O. N., Petrova, M. M., Pozdnyakov, Y. M., Runikhina, N. K., Sayganov, S. A., Tarasov, A. V., Tkacheva, O. N., Urinskiy, A. M., & Shalnova, S. A. (2017). Komorbidnaya patologiya v klinicheskoy praktike. Klinicheskiye rekomendatsii [Comorbid pathology in clinical practice. Clinical recommendations]. Cardiovascular Therapy and Prevention, 16(6), 5–56 (in Russian).

Ogawa, S., Kuroda, K., Kikuchi, T., Shirai, H., Furusawa, M., Akamine, Y., Satoh, T., Fujii, M., Wakayama, S., & Koizumi, M. (1991). The effects of lowering of blood pressure on pain sensitivity in spontaneously hypertensive rats. Japanese Journal of Nephrology: Nihon Jinzo Gakkai Shi, 33(11), 1089–1096.

Olyunin, Y. A. (2017). Primeneniye nesteroidnykh protivovospalitelnykh preparatov u bolnykh s vysokim kardiovaskulyarnym riskom [Use of nonsteroidal anti-inflammatory drugs in patients with high cardiovascular risk]. Rheumatology Science and Practice, 55(3), 321–323 (in Russian).

Rodionov, A. V. (2013). Nesteroidnyye protivovospalitelnyye preparaty i arterialnaya gipertenziya: Aktualnost’ problemy i taktika vedeniya patsiyentov [Nonsteroidal anti-inflammatory drugs and arterial hypertension: The urgency of the problem and patient management tactics]. Attending Doctor, 2, 25–31 (in Russian).

Roubille, C., Fesler, P., & Combe, B. (2019). Shifting from a rheumatologic point of view toward patient-centered care in rheumatoid arthritis with an integrated management of comorbidities. Journal Rheumatology, 46(6), 545–547.

Rudyuk, L. I. (2012). Osoblyvosti likuvannya arterialnoyi hipertenziyi pry revmatoyidnomu artryti [Features of treatment of arterial hypertension at rheumatoid arthritis]. Ukrainian Journal of Rheumatology, 48(2), 53–55 (in Ukrainian).

Saavedra, J. (1981). Naloxone reversible decrease in pain sensitivity in young and adult spontaneously hypertensive rats. Brain Research, 209(1), 245–249.

Saratikov, A. S., Vengerovskiy, A. I., & Prishchep, T. P. (1983). Adyuvantnaya bolezn’ (morfologiya, patogenez, eksperimentalnaya terapiya) [Adjuvant disease (morphology, pathogenesis, experimental therapy)]. Tomsk University Publishing House, Tomsk (in Russian).

Seredynska, N. M., & Pavlyuk, H. V. (2013). Kardiotropna diya inhibitoriv tsoh-1 ta tsoh-2 za umov yikh kompleksnoho zastosuvannya z antahonistom kal’tsiyu dyhidropirydynovoho ryadu na modeli revmatoyidnoho artrytu [Cardiotropic action of tsog-1 and tsog-2 inhibitors under the conditions of their combined application with calcium antagonist of dihydropyridine series in the model of rheumatoid arthritis]. Journal of the National Academy of Medical Sciences of Ukraine, 3, 297–306 (in Ukrainian).

Seredynska, N. M., Khomenko, V. S., Marchenko, O. M., Marchenko-Tolsta, K. S., & Kyrychok, L. M. (2019). Modelyuvannya arterialnoyi hipertenziyi shlyakhom tryvaloho solyovoho navantazhennya. Monitorynh funktsionuvannya sertsevo-sudynnoyi systemy ta dynamiky intehralnykh pokaznykiv zhyttyediyalnosti u shchuriv (chastyna II) [Modeling of arterial hypertension by long-term salt load. Monitoring of the cardiovascular system functioning and the dynamics of integrated vital signs in rats (part II).]. Pharmacology and Drug Toxicology, 13(3), 203–212 (in Ukrainian).

Seredynska, N. M., Kyrychok, L. M., Mokhort, M. A., & Pavlyuk, H. V. (2013). Porivnyalna otsinka protyzapalnoyi aktyvnosti nimesulidu, dyklofenaku ta amlodypinu za adyuvantnoho artrytu [Comparative assessment of the anti-inflammatory activity of nimesulide, diclofenac and amlodipine in adjuvant arthritis]. Pharmacology and Drug Toxicology, 2, 65–69 (in Ukrainian).

Seredynska, N. M., Mokhort, M. A., & Kyrychok, L. M. (2014). Bolyova chutlyvist ta adekvatnist yiyi otsinky za testom “tail flick” u bilykh shchuriv [Pain sensitivity and adequacy of its assessment by the test “tail flick” in white rats]. Pharmacology and Drug Toxicology, 39(3), 45–51 (in Ukrainian).

Shuba, N. M., Voronova, T. D., & Kokunov, Y. O. (2018). NPVS-riski i vybor bezopasnoy terapii [NSAID risks and the choice of safe therapy]. Ukrainian Journal of Rheumatology, 1, 18–22 (in Russian).

Sitsen, J., & de Jong, W. (1983). Hypoalgesia in genetically hypertensive rats (SHR) is absent in rats with experimental hypertension. Hypertension, 5(2), 185–190.

Skorokhodov, A. P., & Polyanskaya, O. V. (2013). Nimesulid: Vozmozhnyye mekhanizmy deystviya, pokazaniya k naznacheniyu, osobennosti primeneniya v klinicheskoy praktike [Nimesulide: Possible mechanisms of action, indications for use, features of application in clinical practice]. Russian Medical Journal, 21(30), 1546–1548 (in Russian).

Trelle, S., Reichenbach, S., Wandel, S., Hildebrand, P., Tschannen, B., Villiger, P. M., Egger, M., & Juni, P. (2011). Cardiovascular safety of non-steroidal anti-inflammatory drugs: Network meta-analysis. BMJ, 342, c7086.

Turesson, C. (2016). Comorbidity in rheumatoid arthritis. Swiss Medical Weekly, 146, w14290.

Wendel, O., & Bennett, T. (1981). The occurrence of analgesia in an animal model of hypertension. Life Sciences, 29(5), 515–521.

Widdifield, J., Paterson, J. M., Huang, A., & Bernatsky, S. (2018). Causes of death in rheumatoid arthritis: How do they compare to the general population? Arthritis Care and Research (Hoboken), 70(12), 1748–1755.

Wojciechowska, M., Wątroba, M., Ciużyńska, G., Bral, M., & Szukiewicz, D. (2013) Ischaemic heart preconditioning in rats with adjuvant-induced arthritis. Kardiologia Polska, 71(8), 839–844.

Yeliseyev, M. S. (2016) Nimesulid v lechenii ostroy boli v revmatologicheskoy praktike: pochemu nisha po-prezhnemu zanyata [Nimesulide in the treatment of acute pain in rheumatological practice: why the niche is still busy]. Medical councilium, 17, 110–112 (in Russian).

Zhuravleva, M. V., Kukes, V. G., Prokof'yev, A. B., & Serebrova, S. Yu. (2016) Ratsionalnoye primeneniye NPVS – balans effektivnosti i bezopasnosti (obzor literatury) [Rational use of NSAIDs - balance of efficacy and safety (literature review)]. International Journal of Applied and Fundamental Research, 6(4), 687–696 (in Russian).

How to Cite
Seredynska, N. M., Kornienko, V. I., Kibkalo, D. V., Suvorova, O. S., Marchenko, O. M., & Ladogubets, O. V. (2020). Amlodipine modulation of analgesic effect of non-steroidal anti-inflammatory drugs in rheumatoid arthritis, comorbid with arterial hypertension . Regulatory Mechanisms in Biosystems, 11(4), 557-562.